Clinical Trial

Tranexamic Acid Infusion During Elective Spine Surgery

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2020 (before its estimated January 1, 2021 completion). Its status may not reflect the trial's current state.
Summary
Tranexamic acid (TXA) is an agent that has been shown to be safe and effective to reduce blood loss in surgical procedures. The purpose of the study is to assess the effect of transexamic on elective decompressive lumbar spine surgery with and without fusion.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-03-16; most recent amendment 2023-08-23.
Status change: Enrolling by Invitation → Completed 2023-08-23
Trial Details
NCT Number NCT04312880
Lead Sponsor Albany Medical College
Conditions Spine Surgery
Enrollment 65 participants
Start Date 2018-12-01
Primary Completion 2021-01-01 (estimated)
Study Completion 2021-01-01 (estimated)
Updated on ClinicalTrials.gov 2020-08-12